🏅 FDA Orphan Designation

Orlaam

Levomethadyl acetate hydrochloride

Manufacturer: Biodevelopment Corporation

Indicated for:

Rare non surgically correctable form of primary aldosteronismOrphanACTH-dependent Cushing syndrome

FDA-Approved Indications (2)

Rare non surgically correctable form of primary aldosteronismOrphan Designation

For the management of opiate dependence.

ACTH-dependent Cushing syndrome

For the management of opiate dependence

Population: all ages

Indications & Usage

For the management of opiate dependence.

💙 Support Programs

View all →

Orlaam

Biodevelopment Corporation

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.